Abstract:Alexander disease (AxD) is a rare and fatal neurodegenerative disorder caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP). In this report, a mouse model of AxD (GFAPTg;Gfap+/R236H) was analyzed that contains a heterozygous R236H point mutation in murine Gfap as well as a transgene with a GFAP promoter to overexpress human GFAP. Using label-free quantitative proteomic comparisons of brain tissue from GFAPTg;Gfap+/R236H versus wild-type mice confirmed upregulation of the glutathione metabolism pathway and indicated proteins were elevated in the peroxisome proliferator-activated receptor (PPAR) signaling pathway, which had not been reported previously in AxD. Relative protein-level differences were confirmed by a targeted proteomics assay, including proteins related to astrocytes and oligodendrocytes. Of particular interest was the decreased level of the oligodendrocyte protein, 2-hydroxyacylsphingosine 1-beta-galactosyltransferase (Ugt8), since Ugt8-deficient mice exhibit a phenotype similar to GFAPTg;Gfap+/R236H mice (e.g., tremors, ataxia, hind-limb paralysis). In addition, decreased levels of myelin-associated proteins were found in the GFAPTg;Gfap+/R236H mice, consistent with the role of Ugt8 in myelin synthesis. Fabp7 upregulation in GFAPTg;Gfap+/R236H mice was also selected for further investigation due to its uncharacterized association to AxD, critical function in astrocyte proliferation, and functional ability to inhibit the anti-inflammatory PPAR signaling pathway in models of amyotrophic lateral sclerosis (ALS). Within Gfap+ astrocytes, Fabp7 was markedly increased in the hippocampus, a brain region subjected to extensive pathology and chronic reactive gliosis in GFAPTg;Gfap+/R236H mice. Last, to determine whether the findings in GFAPTg;Gfap+/R236H mice are present in the human condition, AxD patient and control samples were analyzed by Western blot, which indicated that Type I AxD patients have a significant fourfold upregulation of FABP7. However, immunohistochemistry analysis showed that UGT8 accumulates in AxD patient subpial brain regions where abundant amounts of Rosenthal fibers are located, which was not observed in the GFAPTg;Gfap+/R236H mice.

A Report of Two Cases of Bulbospinal Form Alexander Disease and Preliminary Exploration of the Disease

Adult-onset Alexander disease in people living with HIV and a novel mutation in GFAP

De novo mutations in GFAP cause Alexander disease: clinical features, fMRI and functional analysis

Asymmetric Cerebral Lesion Pattern in X-linked Adrenoleukodystrophy

Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease

Case Report: Alexander's Disease with “head Drop” As the Main Symptom and Literature Review

Clinical Research of 4 Patients with Type Ⅱ Alexander Disease and Literature Review

Glial fibrillary acidic protein is pathologically modified in Alexander disease

Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease

Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis

Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes

Adult-onset Alexander disease among patients of Jewish Syrian descent

[Clinical characteristics and diagnostic criteria on Alexander disease]

Follow-up study of 22 Chinese children with Alexander disease and analysis of parental origin of de novo GFAP mutations

Aberrant neurodevelopment in human iPS cell-derived models of Alexander disease

Clinical and genetic study in chinese patients with alexander disease

Clinical and genetic study of twelve Chinese patients with Alexander disease

A systematic review and meta-analysis of GFAP gene variants in Alexander disease

Leukodystrophy with Macrocephaly, Refractory Epilepsy, and Severe Hyponatremia—The Neonatal Type of Alexander Disease

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

Clinical analysis of type Ⅱ Alexander disease and literature review